First Page | Document Content | |
---|---|---|
P53 Programmed cell death Proteins Biology Cell biology Apoptosis | 1442 Determinants of Demethylation and Clinical Response In AML Patients Treated With SGI-110, a Novel Subcutaneous (SQ) Hypomethylating Agent (HMA) In a Phase 1 Study Woonbok Chung, PhD1, Pietro Taverna, PhD2, John F LAdd to Reading ListSource URL: astx.comDownload Document from Source WebsiteFile Size: 627,94 KBShare Document on Facebook |